article · Journal of basic and applied research international
Liver diseases and hepatotoxicity remain major global health concerns, often resulting from exposure to xenobiotics, drugs, infections, and environmental toxins; which frequently lead to disruption of hepatocyte membranes, causing leakage of intracellular enzymes such as ALT and AST into the bloodstream. This study evaluated the effects of daily administration of aqueous leaf extract of Azadirachta indica on transaminase enzyme activity in Wistar albino rats. Eighty-four rats were randomly assigned into four groups in triplicate containing 7 rats each: control and three treatment groups receiving 200, 400, and 600 mg/kg body weight of the extract, respectively. Following the treatment period, serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined using standard biochemical methods. Results showed that ALT levels decreased across treated groups compared to control, with the lowest value observed at 400 mg/kg, although the differences were not statistically significant (p > 0.05). In contrast, AST levels exhibited a significant reduction (p < 0.05), particularly at the highest dose (600 mg/kg). The findings suggest that aqueous extract of A. indica exerts a modulatory effect on liver enzymes, potentially indicating hepatoprotective activity without inducing hepatic toxicity. These results support the traditional use of neem and highlight its potential role in maintaining liver enzyme homeostasis. However, further studies are required to elucidate the underlying mechanisms and long-term safety of its continuous use.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.56557/jobari/2026/v32i210476
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.